| David Samuel Epstein, MD | |
|
1775 W Hibiscus Blvd, Ste 215, Melbourne, FL 32901-2620 | |
| (321) 837-3820 | |
| Not Available |
| Full Name | David Samuel Epstein |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 24 Years |
| Location | 1775 W Hibiscus Blvd, Melbourne, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033165865 | NPI | - | NPPES |
| P00340067 | Other | RAILROAD MEDICARE # | |
| 001499300 | Medicaid | FL | |
| 1000039991 | Medicaid | DE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morton Plant Hospital | Clearwater, FL | Hospital |
| Mease Dunedin Hospital | Dunedin, FL | Hospital |
| Morton Plant Mease Healthcare Countryside | Safety harbor, FL | Hospital |
| Morton Plant North Bay Hospital | New port richey, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Morton Plant Health Services Inc | 2163336777 | 70 |
| St Josephs Diagnostic Center Llc | 3779484928 | 80 |
| Radiology Associates Of Clearwater | 5496732067 | 48 |
News Archive
Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Scientists have identified key changes in immune cells within cancerous tumors that could help improve the development of treatments.
Only a very few percent of patients that qualify for weight loss surgery actually choose to have it. It is a last resort and most patients do not see themselves as ready to give up. On the other hand, diet and exercise rarely work well and patients are looking for some extra help in their quest to lower their weight. A reversible, non-surgical approach has a lot of appeal to these patients.
A receptor that plays an essential role in safely clearing chronic unresolved cardiac inflammation may offer new targets for treating an increasing type of heart failure associated with age-related obesity, suggests a preclinical study led by researchers at the University of South Florida Health Heart Institute, Morsani College of Medicine.
› Verified 4 days ago
| Entity Name | Morton Plant Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528049962 PECOS PAC ID: 2163336777 Enrollment ID: O20040115000883 |
News Archive
Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Scientists have identified key changes in immune cells within cancerous tumors that could help improve the development of treatments.
Only a very few percent of patients that qualify for weight loss surgery actually choose to have it. It is a last resort and most patients do not see themselves as ready to give up. On the other hand, diet and exercise rarely work well and patients are looking for some extra help in their quest to lower their weight. A reversible, non-surgical approach has a lot of appeal to these patients.
A receptor that plays an essential role in safely clearing chronic unresolved cardiac inflammation may offer new targets for treating an increasing type of heart failure associated with age-related obesity, suggests a preclinical study led by researchers at the University of South Florida Health Heart Institute, Morsani College of Medicine.
› Verified 4 days ago
| Entity Name | St Josephs Diagnostic Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558342998 PECOS PAC ID: 3779484928 Enrollment ID: O20040120000332 |
News Archive
Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Scientists have identified key changes in immune cells within cancerous tumors that could help improve the development of treatments.
Only a very few percent of patients that qualify for weight loss surgery actually choose to have it. It is a last resort and most patients do not see themselves as ready to give up. On the other hand, diet and exercise rarely work well and patients are looking for some extra help in their quest to lower their weight. A reversible, non-surgical approach has a lot of appeal to these patients.
A receptor that plays an essential role in safely clearing chronic unresolved cardiac inflammation may offer new targets for treating an increasing type of heart failure associated with age-related obesity, suggests a preclinical study led by researchers at the University of South Florida Health Heart Institute, Morsani College of Medicine.
› Verified 4 days ago
| Entity Name | Radiology Associates Of Clearwater |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982694899 PECOS PAC ID: 5496732067 Enrollment ID: O20040701000663 |
News Archive
Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Scientists have identified key changes in immune cells within cancerous tumors that could help improve the development of treatments.
Only a very few percent of patients that qualify for weight loss surgery actually choose to have it. It is a last resort and most patients do not see themselves as ready to give up. On the other hand, diet and exercise rarely work well and patients are looking for some extra help in their quest to lower their weight. A reversible, non-surgical approach has a lot of appeal to these patients.
A receptor that plays an essential role in safely clearing chronic unresolved cardiac inflammation may offer new targets for treating an increasing type of heart failure associated with age-related obesity, suggests a preclinical study led by researchers at the University of South Florida Health Heart Institute, Morsani College of Medicine.
› Verified 4 days ago
| Entity Name | Tampa Bay Radiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518914977 PECOS PAC ID: 1456381136 Enrollment ID: O20050813000096 |
News Archive
Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Scientists have identified key changes in immune cells within cancerous tumors that could help improve the development of treatments.
Only a very few percent of patients that qualify for weight loss surgery actually choose to have it. It is a last resort and most patients do not see themselves as ready to give up. On the other hand, diet and exercise rarely work well and patients are looking for some extra help in their quest to lower their weight. A reversible, non-surgical approach has a lot of appeal to these patients.
A receptor that plays an essential role in safely clearing chronic unresolved cardiac inflammation may offer new targets for treating an increasing type of heart failure associated with age-related obesity, suggests a preclinical study led by researchers at the University of South Florida Health Heart Institute, Morsani College of Medicine.
› Verified 4 days ago
| Entity Name | Sheridan Radiology Services Of Pinellas Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083007454 PECOS PAC ID: 7517119407 Enrollment ID: O20121128000124 |
News Archive
Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Scientists have identified key changes in immune cells within cancerous tumors that could help improve the development of treatments.
Only a very few percent of patients that qualify for weight loss surgery actually choose to have it. It is a last resort and most patients do not see themselves as ready to give up. On the other hand, diet and exercise rarely work well and patients are looking for some extra help in their quest to lower their weight. A reversible, non-surgical approach has a lot of appeal to these patients.
A receptor that plays an essential role in safely clearing chronic unresolved cardiac inflammation may offer new targets for treating an increasing type of heart failure associated with age-related obesity, suggests a preclinical study led by researchers at the University of South Florida Health Heart Institute, Morsani College of Medicine.
› Verified 4 days ago
| Entity Name | Brevard Physician Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598008955 PECOS PAC ID: 1850535048 Enrollment ID: O20130909000619 |
News Archive
Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Scientists have identified key changes in immune cells within cancerous tumors that could help improve the development of treatments.
Only a very few percent of patients that qualify for weight loss surgery actually choose to have it. It is a last resort and most patients do not see themselves as ready to give up. On the other hand, diet and exercise rarely work well and patients are looking for some extra help in their quest to lower their weight. A reversible, non-surgical approach has a lot of appeal to these patients.
A receptor that plays an essential role in safely clearing chronic unresolved cardiac inflammation may offer new targets for treating an increasing type of heart failure associated with age-related obesity, suggests a preclinical study led by researchers at the University of South Florida Health Heart Institute, Morsani College of Medicine.
› Verified 4 days ago
| Entity Name | Radiology Physician Solutions Of West Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104205046 PECOS PAC ID: 3577876218 Enrollment ID: O20150723008463 |
News Archive
Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Scientists have identified key changes in immune cells within cancerous tumors that could help improve the development of treatments.
Only a very few percent of patients that qualify for weight loss surgery actually choose to have it. It is a last resort and most patients do not see themselves as ready to give up. On the other hand, diet and exercise rarely work well and patients are looking for some extra help in their quest to lower their weight. A reversible, non-surgical approach has a lot of appeal to these patients.
A receptor that plays an essential role in safely clearing chronic unresolved cardiac inflammation may offer new targets for treating an increasing type of heart failure associated with age-related obesity, suggests a preclinical study led by researchers at the University of South Florida Health Heart Institute, Morsani College of Medicine.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Samuel Epstein, MD 1775 W Hibiscus Blvd, Ste 215, Melbourne, FL 32901-2620 Ph: (321) 837-3820 | David Samuel Epstein, MD 1775 W Hibiscus Blvd, Ste 215, Melbourne, FL 32901-2620 Ph: (321) 837-3820 |
News Archive
Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Scientists have identified key changes in immune cells within cancerous tumors that could help improve the development of treatments.
Only a very few percent of patients that qualify for weight loss surgery actually choose to have it. It is a last resort and most patients do not see themselves as ready to give up. On the other hand, diet and exercise rarely work well and patients are looking for some extra help in their quest to lower their weight. A reversible, non-surgical approach has a lot of appeal to these patients.
A receptor that plays an essential role in safely clearing chronic unresolved cardiac inflammation may offer new targets for treating an increasing type of heart failure associated with age-related obesity, suggests a preclinical study led by researchers at the University of South Florida Health Heart Institute, Morsani College of Medicine.
› Verified 4 days ago
Thomas H Magee, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 709 S Harbor City Blvd Ste 100, Melbourne, FL 32901 Phone: 321-409-9900 Fax: 321-309-9033 | |
Dr. Irina S Mezheritskiy, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1350 S Hickory St, Holmes Regional Medical Center/radiology, Melbourne, FL 32901 Phone: 321-434-7313 Fax: 321-434-7238 | |
Dr. Charles Ehlenberger, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1350 Hickory Street, Melbourne, FL 32901 Phone: 321-434-7000 | |
Dr. Santiago Jimenez, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr, Melbourne, FL 32901 Phone: 321-549-0677 | |
Steven D Picerne, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1800 W Hibiscus Blvd Ste 100, Melbourne, FL 32901 Phone: 321-726-3800 | |
Dr. Brent D Brandon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1350 S Hickory St, Holmes Regional Medical Center/radiology, Melbourne, FL 32901 Phone: 321-434-7313 Fax: 321-434-7238 |